File Download
Supplementary

Conference Paper: A randomized, double-blind, multicenter phase 3 study of brivanib versus placebo as adjuvant therapy to trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma: initial results

TitleA randomized, double-blind, multicenter phase 3 study of brivanib versus placebo as adjuvant therapy to trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma: initial results
Authors
Kudo, MFinn, RPoon, RTPBlanc, JFHan, GYan, LYang, JLu, LTak, WYXU, XLee, JHLin, SMWu, CTanwandee, TShao, GWalters, LDela Cruz, CPoulart, VWang, JH
Issue Date2013
PublisherInternational Liver Cancer Association.
Citation
The 7th Annual Conference of the International Liver Cancer Association (ILCA), Washington, DC., 13-15 September 2013. In Final program & book of abstracts, 2013, p. 16 How to Cite?
DescriptionThe 7th Annual Conference of the International Liver Cancer Association (ILCA), Washington, D.C., USA, 13-15 September, 2013
Oral Communications, Saturday 14 September, 2013, 0-022
Persistent Identifierhttp://hdl.handle.net/10722/195840

 

DC FieldValueLanguage
dc.contributor.authorKudo, M-
dc.contributor.authorFinn, R-
dc.contributor.authorPoon, RTP-
dc.contributor.authorBlanc, JF-
dc.contributor.authorHan, G-
dc.contributor.authorYan, L-
dc.contributor.authorYang, J-
dc.contributor.authorLu, L-
dc.contributor.authorTak, WY-
dc.contributor.authorXU, X-
dc.contributor.authorLee, JH-
dc.contributor.authorLin, SM-
dc.contributor.authorWu, C-
dc.contributor.authorTanwandee, T-
dc.contributor.authorShao, G-
dc.contributor.authorWalters, L-
dc.contributor.authorDela Cruz, C-
dc.contributor.authorPoulart, V-
dc.contributor.authorWang, JH-
dc.date.accessioned2014-03-14T03:01:45Z-
dc.date.available2014-03-14T03:01:45Z-
dc.date.issued2013-
dc.identifier.citationThe 7th Annual Conference of the International Liver Cancer Association (ILCA), Washington, DC., 13-15 September 2013. In Final program & book of abstracts, 2013, p. 16-
dc.identifier.urihttp://hdl.handle.net/10722/195840-
dc.descriptionThe 7th Annual Conference of the International Liver Cancer Association (ILCA), Washington, D.C., USA, 13-15 September, 2013-
dc.descriptionOral Communications, Saturday 14 September, 2013, 0-022-
dc.languageeng-
dc.publisherInternational Liver Cancer Association.-
dc.relation.ispartofAnnual Conference of the International Liver Cancer Association, ILCA 2013-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleA randomized, double-blind, multicenter phase 3 study of brivanib versus placebo as adjuvant therapy to trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma: initial resultsen_US
dc.typeConference_Paperen_US
dc.identifier.emailPoon, RTP: poontp@hku.hk-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.spage16-
dc.identifier.epage16-
dc.identifier.epage16-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats